Compare MAIA & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MAIA | ABLV |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 39.5M |
| IPO Year | 2022 | N/A |
| Metric | MAIA | ABLV |
|---|---|---|
| Price | $2.16 | $0.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 622.1K | 17.9K |
| Earning Date | 11-07-2025 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $114,319,869.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.87 | $0.59 |
| 52 Week High | $2.74 | $1.77 |
| Indicator | MAIA | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 74.91 | 42.46 |
| Support Level | $1.49 | $0.67 |
| Resistance Level | $1.71 | $0.85 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 99.99 | 22.65 |
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.